Category: Big Data Analytics

Transvenous ICD Leads Associated with Tricuspid Regurgitation: ATLAS Trial Uncovers Potential Outcomes

The ATLAS trial highlights the impact of implantable cardioverter defibrillator (ICD) leads on tricuspid regurgitation. Findings show that patients with transvenous leads experience worse outcomes related to tricuspid regurgitation compared to those with subcutaneous leads. Further research is needed to explore the implications of this relationship on patient health.

Read More
Loading